284 related articles for article (PubMed ID: 21747916)
21. Decreased Mdm2 expression inhibits tumor development and extends survival independent of Arf and dependent on p53.
Eischen CM; Boyd K
PLoS One; 2012; 7(9):e46148. PubMed ID: 23029416
[TBL] [Abstract][Full Text] [Related]
22. MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation.
Qi DL; Cobrinik D
Oncogene; 2017 Mar; 36(13):1760-1769. PubMed ID: 27748758
[TBL] [Abstract][Full Text] [Related]
23. Oncogenic ras and p53 cooperate to induce cellular senescence.
Ferbeyre G; de Stanchina E; Lin AW; Querido E; McCurrach ME; Hannon GJ; Lowe SW
Mol Cell Biol; 2002 May; 22(10):3497-508. PubMed ID: 11971980
[TBL] [Abstract][Full Text] [Related]
24. Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation.
Lindström MS; Jin A; Deisenroth C; White Wolf G; Zhang Y
Mol Cell Biol; 2007 Feb; 27(3):1056-68. PubMed ID: 17116689
[TBL] [Abstract][Full Text] [Related]
25. Regulation of the MDM2-p53 pathway by ribosomal protein L11 involves a post-ubiquitination mechanism.
Dai MS; Shi D; Jin Y; Sun XX; Zhang Y; Grossman SR; Lu H
J Biol Chem; 2006 Aug; 281(34):24304-13. PubMed ID: 16803902
[TBL] [Abstract][Full Text] [Related]
26. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T
Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748
[TBL] [Abstract][Full Text] [Related]
27. Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro.
Schrage YM; Lam S; Jochemsen AG; Cleton-Jansen AM; Taminiau AH; Hogendoorn PC; Bovée JV
J Cell Mol Med; 2009 Sep; 13(9A):2843-52. PubMed ID: 18624751
[TBL] [Abstract][Full Text] [Related]
28. Oncogenic MYC Induces the Impaired Ribosome Biogenesis Checkpoint and Stabilizes p53 Independent of Increased Ribosome Content.
Morcelle C; Menoyo S; Morón-Duran FD; Tauler A; Kozma SC; Thomas G; Gentilella A
Cancer Res; 2019 Sep; 79(17):4348-4359. PubMed ID: 31292158
[TBL] [Abstract][Full Text] [Related]
29. Ribosomal stress induces L11- and p53-dependent apoptosis in mouse pluripotent stem cells.
Morgado-Palacin L; Llanos S; Serrano M
Cell Cycle; 2012 Feb; 11(3):503-10. PubMed ID: 22262176
[TBL] [Abstract][Full Text] [Related]
30. Ribosomal protein S27-like is a physiological regulator of p53 that suppresses genomic instability and tumorigenesis.
Xiong X; Zhao Y; Tang F; Wei D; Thomas D; Wang X; Liu Y; Zheng P; Sun Y
Elife; 2014 Aug; 3():e02236. PubMed ID: 25144937
[TBL] [Abstract][Full Text] [Related]
31. The Evolution of the Ribosomal Protein-MDM2-p53 Pathway.
Deisenroth C; Franklin DA; Zhang Y
Cold Spring Harb Perspect Med; 2016 Dec; 6(12):. PubMed ID: 27908926
[TBL] [Abstract][Full Text] [Related]
32. Putting a finger on growth surveillance: insight into MDM2 zinc finger-ribosomal protein interactions.
Lindström MS; Deisenroth C; Zhang Y
Cell Cycle; 2007 Feb; 6(4):434-7. PubMed ID: 17329973
[TBL] [Abstract][Full Text] [Related]
33. Ribosomal proteins RPL37, RPS15 and RPS20 regulate the Mdm2-p53-MdmX network.
Daftuar L; Zhu Y; Jacq X; Prives C
PLoS One; 2013; 8(7):e68667. PubMed ID: 23874713
[TBL] [Abstract][Full Text] [Related]
34. Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF.
Ries S; Biederer C; Woods D; Shifman O; Shirasawa S; Sasazuki T; McMahon M; Oren M; McCormick F
Cell; 2000 Oct; 103(2):321-30. PubMed ID: 11057904
[TBL] [Abstract][Full Text] [Related]
35. Perturbation of 60 S ribosomal biogenesis results in ribosomal protein L5- and L11-dependent p53 activation.
Sun XX; Wang YG; Xirodimas DP; Dai MS
J Biol Chem; 2010 Aug; 285(33):25812-21. PubMed ID: 20554519
[TBL] [Abstract][Full Text] [Related]
36. Regulation of Actinomycin D induced upregulation of Mdm2 in H1299 cells.
Li L; Cui D; Zheng SJ; Lou H; Tang J
DNA Repair (Amst); 2012 Feb; 11(2):112-9. PubMed ID: 22051195
[TBL] [Abstract][Full Text] [Related]
37. Aberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancer.
Inoue K; Fry EA
Int J Cancer; 2016 Jul; 139(1):33-41. PubMed ID: 26802432
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of the p53-MDM2 interaction by adenovirus delivery of ribosomal protein L23 stabilizes p53 and induces cell cycle arrest and apoptosis in gastric cancer.
Zhang Y; Shi Y; Li X; Du W; Luo G; Gou Y; Wang X; Guo X; Liu J; Ding J; Wu K; Fan D
J Gene Med; 2010 Feb; 12(2):147-56. PubMed ID: 20020415
[TBL] [Abstract][Full Text] [Related]
39. The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor.
Manfredi JJ
Genes Dev; 2010 Aug; 24(15):1580-9. PubMed ID: 20679392
[TBL] [Abstract][Full Text] [Related]
40. Multiple stress signals activate mutant p53 in vivo.
Suh YA; Post SM; Elizondo-Fraire AC; Maccio DR; Jackson JG; El-Naggar AK; Van Pelt C; Terzian T; Lozano G
Cancer Res; 2011 Dec; 71(23):7168-75. PubMed ID: 21983037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
